Brian G. Atwood is Director at CADENCE PHARMACEUTICALS INC (CADX). They have made 9 open-market trades across 6 companies since 2007, most recently 2025-03-31.
CIK 0001429386
7 open-market purchases totalling $15.5M since 2007, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PODD | 1,957,713 | $276.2M |
| FPRX | 1,092,152 | $41.5M |
| IMDZ | 1,974,877 | $11.6M |
| VCYT | 21,232 | $916K |
| INGN | 16,329 | $102K |
| CERO | 490,534 | $47K |
| BCEL | 49,654 | $7K |
| PZRX | 11,408 | $3K |
| CLVS | 32,758 | $3K |
| CADX | 1,685,591 | — |
| OPGN,OPGNW | 2,554,211 | — |
| TSRX | 1,576,814 | — |
| HLCS | 10,709,818 | — |
| Total | $330.3M |
Shares reported on the most recent Form 4, priced at the 2025-04-04 close. 4 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PZRX | SELL | 2016-05-23 | 2016-05-24 | $0.01 | $3K | +6.9% | -5.7% | -38.0% |
| PZRX | BUY | 2016-05-23 | 2016-05-24 | $5.00 | $3.0M | +6.9% | -5.7% | -38.0% |
| OPGN,OPGNW | BUY | 2015-05-08 | 2015-05-12 | $6.00 | $2.5M | N/A | N/A | N/A |
| IMDZ | BUY | 2014-07-29 | 2014-07-31 | $12.00 | $2.8M | -45.2% | -0.3% | -0.3% |
| IMDZ | SELL | 2014-07-29 | 2014-07-31 | $12.00 | $2.5M | -45.2% | -0.3% | -0.3% |
| FPRX | BUY | 2013-09-23 | 2013-09-24 | $13.00 | $1000K | -18.3% | -4.1% | -4.1% |
| TSRX | BUY | 2010-08-06 | 2010-08-10 | $5.00 | $4.6M | N/A | N/A | N/A |
| HLCS | BUY | 2009-09-18 | 2009-09-21 | $2.57 | $624K | N/A | N/A | N/A |
| HLCS | BUY | 2007-05-30 | 2007-06-01 | $9.00 | $1000K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.